CHE
Chemed Corp.
Data as of 2026-09-05
Company attributes
Price
Interactive 5-year price history chart for CHE. Latest close $524.45.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency90ExceptionalHealth Care median (n=163) 51
- ValuePrice vs fundamentals54AverageHealth Care median (n=163) 51
- GrowthRevenue & earnings trajectory44AverageHealth Care median (n=163) 50
- MomentumRecent price strength77ExceptionalHealth Care median (n=163) 62
- HealthBalance sheet & solvency63StrongHealth Care median (n=163) 56
- ProfitabilityROE, ROA, ROIC69StrongHealth Care median (n=163) 49
- TechnicalTrend & volatility signals70ExceptionalHealth Care median (n=163) 62
- RiskVolatility & drawdown profile57StrongHealth Care median (n=163) 47
Pillars not shown: Sentiment, ML (Phase 5+).
Risk Summary
Low- Restatement history (10-K/A, 5y)[restatement_history]
- C-suite unusual selling (Jeng-Metrick-Zeckhauser 2003)[c_suite_unusual_sell]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
6 different valuation methods each estimate what CHE should be worth, then we compare to today's price.
- P/E multiplesFairthinks it's fairly priced — estimates $554.99, about 6% above today
- EV/EBITDAFairthinks it's fairly priced — estimates $483.32, about 8% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $271.53, about 48% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $218.92, about 58% below today
- Graham (defensive)Outlierestimate looks unreliable — estimates $41.14 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $7.81 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $245.23
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $554.99
- Tangible BVPS
- $4.02
- Goodwill-heavy balance sheet
- Extreme Graham estimate
- Extreme Residual-Income estimate
- Restatement history
- C-suite unusual selling
Median of all applicable methods (current price $524.45). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $6.85B |
| Revenue (TTM) | $2.60B |
| Net income (TTM) | $274.99M |
| Operating cash flow (TTM) | $389.95M |
| CapEx (TTM) | $66.35M |
| Free cash flow (TTM)CFO − CapEx | $323.61M |
| Total assets | $1.58B |
| Total liabilities | $749.08M |
| Stockholders' equity | $830.51M |
| Cash & equivalents | $40.22M |
| Shares outstanding | 13.07M |
| EPS (basic) | $21.04 |
| EPS (diluted) | $21.04 |
| P/E ratio (TTM) | 24.93 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-07-31
- Latest period end
- 2026-06-30
- Filing lag
- 36 days
- Missing metrics
- 2(gross_profit, research_and_development)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.